Banyan Partners’s Core Laboratories CLB Stock Holding History

Banyan Partners’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-2,765	Closed	-$468K	–	407
2013 Q3	$468K	Buy	+2,765	New	+$429K	0.04%	226

Other funds holding CLB

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Banyan Partners's CLB Position: Q4 2013 in Review

Banyan Partners sold out of Core Laboratories (CLB) in Q4 2013, closing a stake of 2,765 shares — an estimated $468K sold.

Banyan Partners first reported a position in CLB in Q3 2013 and held it in 1 quarter. The position peaked at $468K in Q3 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2013.

Banyan Partners reported no remaining Core Laboratories position as of Q4 2013 after selling out during the quarter.
Banyan Partners sold 2,765 Core Laboratories shares in Q4 2013, an estimated $468K.
Banyan Partners first reported a position in Core Laboratories in Q3 2013 and held it in 1 quarter.
Banyan Partners's Core Laboratories position peaked at $468K in Q3 2013.
345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2013.

Based on Banyan Partners's 13F filing for Q4 2013, filed 12 Feb 2014.